临床肿瘤学杂志
臨床腫瘤學雜誌
림상종류학잡지
CHINESE CLINICAL ONCOLOGY
2014年
11期
972-976
,共5页
孙国贵%张洁%崔大为%李成林%杨从容%张钧%程云杰
孫國貴%張潔%崔大為%李成林%楊從容%張鈞%程雲傑
손국귀%장길%최대위%리성림%양종용%장균%정운걸
B细胞易位基因1(BTG1)%非小细胞肺癌%基因转染%肿瘤转移
B細胞易位基因1(BTG1)%非小細胞肺癌%基因轉染%腫瘤轉移
B세포역위기인1(BTG1)%비소세포폐암%기인전염%종류전이
B-cell translocation gene 1( BTG1)%Non-small cell lung cancer( NSCLC)%Gene transfection%Tumor me-tastasis
目的:探讨B细胞易位基因1( BTG1)在非小细胞肺癌( NSCLC)组织中的表达及其对NSCLC细胞生物学行为的影响。方法采用免疫组织化学染色和Western blotting分别检测82例NSCLC及38例癌旁正常组织中BTG1蛋白的表达。采用慢病毒转染建立BTG1过表达的NSCLC H1299细胞株。采用实时荧光定量PCR和Western blotting检测BTG1转染后H1299细胞株中BTG1表达含量的变化。采用MTT法、流式细胞术及Transwell法检测BTG1过表达对NSCLC细胞增殖、凋亡及侵袭转移的影响。结果 BTG1蛋白在NSCLC及癌旁正常组织中的阳性表达率分别为37?8%(31/82)、84?2%(32/38),差异有统计学意义(P<0?05)。 NSCLC组织中BTG1蛋白的相对表达量为0?331±0?035,明显低于癌旁正常组织的0?673±0?072,差异有统计学意义(P<0?05)。 NSCLC组织中BTG1的表达与淋巴结转移、临床分期和组织学分级有关(P<0?05)。 BTG1过表达的NSCLC细胞增殖能力明显减弱、细胞凋亡增加及侵袭转移能力降低,且Bcl?2、MMP?9表达量明显下调。结论 NSCLC组织中BTG1蛋白的表达明显降低;BTG1可能通过调控Bcl?2及MMP?9蛋白的表达影响NSCLC细胞的增殖、凋亡与转移。
目的:探討B細胞易位基因1( BTG1)在非小細胞肺癌( NSCLC)組織中的錶達及其對NSCLC細胞生物學行為的影響。方法採用免疫組織化學染色和Western blotting分彆檢測82例NSCLC及38例癌徬正常組織中BTG1蛋白的錶達。採用慢病毒轉染建立BTG1過錶達的NSCLC H1299細胞株。採用實時熒光定量PCR和Western blotting檢測BTG1轉染後H1299細胞株中BTG1錶達含量的變化。採用MTT法、流式細胞術及Transwell法檢測BTG1過錶達對NSCLC細胞增殖、凋亡及侵襲轉移的影響。結果 BTG1蛋白在NSCLC及癌徬正常組織中的暘性錶達率分彆為37?8%(31/82)、84?2%(32/38),差異有統計學意義(P<0?05)。 NSCLC組織中BTG1蛋白的相對錶達量為0?331±0?035,明顯低于癌徬正常組織的0?673±0?072,差異有統計學意義(P<0?05)。 NSCLC組織中BTG1的錶達與淋巴結轉移、臨床分期和組織學分級有關(P<0?05)。 BTG1過錶達的NSCLC細胞增殖能力明顯減弱、細胞凋亡增加及侵襲轉移能力降低,且Bcl?2、MMP?9錶達量明顯下調。結論 NSCLC組織中BTG1蛋白的錶達明顯降低;BTG1可能通過調控Bcl?2及MMP?9蛋白的錶達影響NSCLC細胞的增殖、凋亡與轉移。
목적:탐토B세포역위기인1( BTG1)재비소세포폐암( NSCLC)조직중적표체급기대NSCLC세포생물학행위적영향。방법채용면역조직화학염색화Western blotting분별검측82례NSCLC급38례암방정상조직중BTG1단백적표체。채용만병독전염건립BTG1과표체적NSCLC H1299세포주。채용실시형광정량PCR화Western blotting검측BTG1전염후H1299세포주중BTG1표체함량적변화。채용MTT법、류식세포술급Transwell법검측BTG1과표체대NSCLC세포증식、조망급침습전이적영향。결과 BTG1단백재NSCLC급암방정상조직중적양성표체솔분별위37?8%(31/82)、84?2%(32/38),차이유통계학의의(P<0?05)。 NSCLC조직중BTG1단백적상대표체량위0?331±0?035,명현저우암방정상조직적0?673±0?072,차이유통계학의의(P<0?05)。 NSCLC조직중BTG1적표체여림파결전이、림상분기화조직학분급유관(P<0?05)。 BTG1과표체적NSCLC세포증식능력명현감약、세포조망증가급침습전이능력강저,차Bcl?2、MMP?9표체량명현하조。결론 NSCLC조직중BTG1단백적표체명현강저;BTG1가능통과조공Bcl?2급MMP?9단백적표체영향NSCLC세포적증식、조망여전이。
Objective To investigate the expression of B?cell translocation gene 1 ( BTG1 ) in non?small cell lung cancer ( NSCLC) and its biological effect in NSCLC cell line by BTG1 overexpression. Methods Immunohistochemistry and Western blotting were used to detect BTG1 protein expression in 82 cases of NSCLC and 38 cases of adjacent normal lung tissues, and the relationship between BTG1 expression and clinicopathological characteristics was analyzed. BTG1 lentiviral vector and empty vector were respectively transfected into NSCLC H1299 cell line. Quantitative real?time RT?PCR( qRT?PCR) and Western blotting were used to de?tect the mRNA and protein level of BTG1. MTT assay, flow cytometry and Transwell assay were also used to detect the effects of the up?regulated expression of BTG1 on H1299 cell proliferation, apoptosis and invasion. Results The positive expression rate of BTG1 pro?tein was 37?8%(31/82) in NSCLC tissues, significantly lower than 84?2%(32/38) in adjacent normal lung tissues(P<0?05). The relative amount of BTG1 protein in NSCLC tissues was 0?331±0?035, significantly lower than 0?673±0?072 in adjacent normal lung tissues( P<0?05) . The level of BTG1 protein expression was correlated with lymph node metastasis, clinical stage and histological grade( P<0?05) . The result of biological function had shown that H1299 cell transfected BTG1 had a lower survival fraction, higher cell apoptosis, and significant decrease in migration and invasion, and lower Bcl?2, MMP?9 protein expression compared with H1299 cell untransfected BTG1( P<0?05) . Conclusion BTG1 expression is decreased in NSCLC tissues, suggesting that BTG1 may play an important role as a negative regulator to NSCLC H1299 cell by promoting degradation of Bcl?2 and MMP?9 protein.